Comparison the efficacy and safety of focused ultrasound and halcinonide on white lesions of the vulva: a multi-center randomized controlled trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-09000434

Enrollment

Unknown

Registered

2009-06-05

Start date

2009-07-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

white lesions of the vulva

Interventions

1:focused ultrasound

2:focused ultrasound

Eligibility

Sex/Gender

Female

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Women Aged 20 to 70 years old; 2. Patients who are in accordance with clinical diagnosis standard of nonneoplastic epithelial disorders of vulva; 3. Lesion were in labium majus pudendil, labium minus pudenda, nympholabial furrow, praeputium clitoridis and commissura posterior; 4. Biopsy of Vulva indicated chronic inflammatory of skin of vulva; 5. Patients received no other physicotherapeutics or glucocorticoid in last 3 months before enrollment.

Exclusion criteria

Exclusion criteria: 1. Patients who were contradicted to general and local anesthesia or sedatives; 2. Patients with severe heart, brain or vascular disease or dysfunction in hepatic or kidney function; 3. Patients with acute infections in reproductive organ; 4. Patients in menstrual period, pregnancy or lactation; 5. Biopsy of Vulva indicated neoplastic epithelial disorders of vulva; 6. Patients with uncontrolled diabetes.

Design outcomes

Primary

Measure	Time frame
Effect index;	—

Secondary

Measure	Time frame
Symptoms improvements;Quality of Life;	—

Countries

China

Contacts

Public ContactLan Zhu

zhu_julie@sina.com+86 0 13911714696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026